Login to Your Account



Proximagen Sells Clinical-Stage Compound in $51M Deal

By Catherine Hollingsworth


Wednesday, August 11, 2010
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription